Search Items: PROSTATE CANCER DETECTION, . hits: 6
Mischinger, J; Schöllnast, H; Zurl, H; Geyer, M; Fischereder, K; Adelsmayr, G; Igrec, J; Fritz, G; Merdzo-Hörmann, M; Elstner, J; Schmid, J; Triebl, A; Trimmel, V; Reiter, C; Steiner, J; Rosenlechner, D; Seles, M; Pichler, GP; Pichler, M; Riedl, J; Schöpfer-Schwab, S; Strobl, J; Hutterer, GC; Zigeuner, R; Pummer, K; Augustin, H; Ahyai, S; Mannweiler, S; Fuchsjäger, M; Talakic, E
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients.
Front Surg. 2022; 9: 1013389
Doi: 10.3389/fsurg.2022.1013389
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lodeta, B; Trkulja, V; Kolroser-Sarmiento, G; Jozipovic, D; Salmhofer, A; Augustin, H
Systematic biopsy should not be omitted in the era of combined magnetic resonance imaging/ultrasound fusion-guided biopsies of the prostate.
Int Urol Nephrol. 2021; 53(11): 2251-2259.
Doi: 10.1007/s11255-021-02989-2
Web of Science
PubMed
FullText
FullText_MUG
Mischinger, J; Kaufmann, S; Russo, GI; Harland, N; Rausch, S; Amend, B; Scharpf, M; Loewe, L; Todenhoefer, T; Notohamiprodjo, M; Nikolaou, K; Stenzl, A; Bedke, J; Kruck, S
Targeted vs systematic robot-assisted transperineal magnetic resonance imaging-transrectal ultrasonography fusion prostate biopsy.
BJU Int. 2018; 121(5):791-798
Doi: 10.1111/bju.14089
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Seles, M; Gutschi, T; Mayrhofer, K; Fischereder, K; Ehrlich, G; Gallé, G; Gutschi, S; Pachernegg, O; Pummer, K; Augustin, H
Sampling of the anterior apical region results in increased cancer detection and upgrading in transrectal repeat saturation biopsy of the prostate.
BJU Int. 2016; 117(4):592-597
Doi: 10.1111/bju.13108
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Auprich, M; Bjartell, A; Chun, FK; de la Taille, A; Freedland, SJ; Haese, A; Schalken, J; Stenzl, A; Tombal, B; van der Poel, H
Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
Eur Urol. 2011; 60(5):1045-1054
Doi: 10.1016/j.eururo.2011.08.003
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Brossner, C; Winterholer, A; Roehlich, M; Dlouhy-Schütz, E; Serra, V; Sonnleithner, M; Grubmüller, KH; Pummer, K; Schuster, E
Distribution of prostate carcinoma foci within the peripheral zone: analysis of 8,062 prostate biopsy cores.
World J Urol. 2003; 21(3):163-166
Doi: 10.1007/s00345-003-0341-4
Web of Science
PubMed
FullText
FullText_MUG